Navigation Links
HUNT Biosciences and SomaLogic collaborate to validate protein biomarkers of cardiovascular risk
Date:4/10/2012

Levanger, Norway and Boulder, CO, USA -- April 10, 2012 -- HUNT Biosciences and SomaLogic, Inc., today announced a new collaboration to advance the clinical use of protein biomarkers, with an initial focus on the validation of biomarkers for the prediction of cardiovascular events such as strokes, heart attacks, and heart failure.

The collaboration will analyze biological samples and clinical data from HUNT Biosciences using SomaLogic's unique SOMAscan proteomic technology. HUNT Biosciences will work with SomaLogic to select and supply samples and accompanying clinical data and selected phenotype information from up to 2000 of the more than 100 000 participants in the large HUNT health study.

"We believe the HUNT health study offers samples and data that will help identify and validate protein biomarkers of high clinical significance," said Dr. Per A. Foss, CEO of HUNT Biosciences. "SomaLogic has a promising technology and the company shares our vision of the importance of biomarkers to improve healthcare. We believe this collaboration has a significant potential and could be extended to include other medical conditions that will benefit from the discovery and use of well-documented biomarkers".

"We are delighted to work with HUNT biosciences to develop new diagnostic tools that predict cardiovascular risk," said Stephen Williams, Chief Medical Officer of SomaLogic. "The clinical sample cohort available through the HUNT health study is among the broadest in the world, and we believe that our technology is uniquely capable of deriving new clinical insights from those samples that can lead to new diagnostics and acceleration of drug discovery and development efforts to the benefit of patients everywhere."


'/>"/>

Contact: Fintan R. Steele, Ph.D.
fsteele@somalogic.com
720-214-3080
SomaLogic, Inc.
Source:Eurekalert

Page: 1

Related biology news :

1. TGen Drug Development recognized for economic development of Arizona biosciences
2. BD Biosciences Introduces Chemically Defined Cell Culture Media Supplement that Increases Biopharmaceutical Protein Production
3. Stanford professor honored for contributions to computational biosciences
4. Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute
5. Avantra Biosciences teams with TGen Drug Development to assist pharma
6. Human cells can copy not only DNA, but also RNA, says team from Pitt, Helicos BioSciences
7. InQ Biosciences Introduces First Fully Integrated Cell Research System
8. Energy Biosciences Institue named "Deal of Distinction" by tech-transfer group
9. SomaLogic Inc. receives Grand Challenges tuberculosis biomarkers grant
10. SomaLogic and Ambergen announce agreement for commercial applications of photocleavable biotin
11. SomaLogic announces agreement with leading global pharma company to accelerate R&D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2017)... 7, 2017 Brandwatch , the leading social intelligence ... Prince,s Trust to uncover insights to support its reporting, help ... The UK,s leading youth charity will be using Brandwatch Analytics ... get a better understanding of the topics and issues that are ... ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
Breaking Biology Technology: